SARS-CoV-2 N Polyclonal Antibody

$Lane 1~6: Recombinant SARS-CoV Nucleocapsid protein; Lane 7~12: Recombinant SARS-CoV-2 Nucleocapsid Protein probed with SARS-CoV-2 N Polyclonal Antibody, Unconjugated (bs-41417R) at 1:2000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1~6: Recombinant SARS-CoV Nucleocapsid protein; Lane 7~12: Recombinant SARS-CoV-2 Nucleocapsid Protein probed with SARS-CoV-2 N Polyclonal Antibody, Unconjugated (bs-41417R) at 1:2000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

Overview
Catalog #	bs-41417R
Product Name	SARS-CoV-2 N Polyclonal Antibody
Applications	WB
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Histone H1.2
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Synonyms	SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein.
Application Dilution
WB	1:300-5000